These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24192318)

  • 1. Sacroiliitis in a psoriasis patient after switching from etanercept to ustekinumab.
    Vilaça S; Torres T; Selores M
    Eur J Dermatol; 2013; 23(6):897-8. PubMed ID: 24192318
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of tumor necrosis factor inhibitors in acute generalized pustular psoriasis.
    Viguier M; Aubin F; Delaporte E; Pagès C; Paul C; Beylot-Barry M; Goujon C; Rybojad M; Bachelez H;
    Arch Dermatol; 2012 Dec; 148(12):1423-5. PubMed ID: 23247492
    [No Abstract]   [Full Text] [Related]  

  • 3. Biological treatments for moderate-to-severe psoriasis: indirect comparison.
    Galván-Banqueri M; Marín Gil R; Santos Ramos B; Bautista Paloma FJ
    J Clin Pharm Ther; 2013 Apr; 38(2):121-30. PubMed ID: 23442134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etanercept-induced asthma in a psoriatic patient resolving with transition to ustekinumab.
    Torres T; Vilaça S; Velho G; Selores M
    Eur J Dermatol; 2012; 22(5):696-7. PubMed ID: 22910198
    [No Abstract]   [Full Text] [Related]  

  • 5. Psoriasis options abound. Ongoing research on Enbrel and Raptiva supports their use in psoriasis treatment.
    Krueger GG
    Health News; 2004 Jan; 10(1):10-1. PubMed ID: 15002383
    [No Abstract]   [Full Text] [Related]  

  • 6. Ixekizumab for psoriasis.
    Tsuda K; Tanimoto T; Takenouchi S; Sakaue S; Komatsu T
    Lancet; 2016 Jan; 387(10015):225-6. PubMed ID: 26842296
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficiency and safety of etanercept after acute hepatitis induced by infliximab for psoriasis.
    Kluger N; Girard C; Guillot B; Bessis D
    Acta Derm Venereol; 2009; 89(3):332-4. PubMed ID: 19479148
    [No Abstract]   [Full Text] [Related]  

  • 8. Ixekizumab for psoriasis--Authors' reply.
    Griffiths CE; Papp KA; Ball SG; Nickoloff BJ
    Lancet; 2016 Jan; 387(10015):226-7. PubMed ID: 26842297
    [No Abstract]   [Full Text] [Related]  

  • 9. Interleukin-17 inhibition: a route to psoriasis clearance?
    Bachelez H
    Lancet; 2015 Aug; 386(9993):510-2. PubMed ID: 26072106
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety and efficacy study on etanercept in patients with plaque psoriasis.
    Costanzo A; Mazzotta A; Papoutsaki M; Nisticò S; Chimenti S
    Br J Dermatol; 2005 Jan; 152(1):187-9. PubMed ID: 15656833
    [No Abstract]   [Full Text] [Related]  

  • 11. Dermatologist preferences for treatments to compare in future randomized controlled comparative effectiveness trials for moderate to severe psoriasis.
    Wan J; Abuabara K; Troxel AB; Shin DB; Van Voorhees AS; Bebo BF; Krueger GG; Callis Duffin K; Gelfand JM
    Arch Dermatol; 2012 Apr; 148(4):539-41. PubMed ID: 22508884
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and safety of etanercept in patients with psoriasis and hepatitis C.
    Ventura F; Gomes J; Duarte Mda L; Fernandes JC; Brito C
    Eur J Dermatol; 2010; 20(6):808-9. PubMed ID: 20923749
    [No Abstract]   [Full Text] [Related]  

  • 13. Adalimumab vs. etanercept in psoriasis.
    Downs AM
    Clin Exp Dermatol; 2007 Sep; 32(5):593. PubMed ID: 17692064
    [No Abstract]   [Full Text] [Related]  

  • 14. Psoriasis: Is ustekinumab superior to etanercept for psoriasis?
    Kuhn A; Luger TA
    Nat Rev Rheumatol; 2010 Sep; 6(9):500-1. PubMed ID: 20808304
    [No Abstract]   [Full Text] [Related]  

  • 15. Switching to adalimumab in patients with moderate to severe psoriasis who have failed on etanercept: a retrospective case cohort study.
    Woolf RT; Smith CH; Robertson K; Barker JN
    Br J Dermatol; 2010 Oct; 163(4):889-92. PubMed ID: 20854408
    [No Abstract]   [Full Text] [Related]  

  • 16. 'Happy' drug survival of adalimumab, etanercept and ustekinumab in psoriasis in daily practice care: results from the BioCAPTURE network.
    van den Reek JM; Zweegers J; Kievit W; Otero ME; van Lümig PP; Driessen RJ; Ossenkoppele PM; Njoo MD; Mommers JM; Koetsier MI; Arnold WP; Sybrandy-Fleuren BA; Kuijpers AL; Andriessen MP; van de Kerkhof PC; Seyger MM; de Jong EM
    Br J Dermatol; 2014 Nov; 171(5):1189-96. PubMed ID: 24807471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe generalized exanthema due to etanercept given for severe plaque psoriasis.
    Gonzalo-Garijo MA; Pérez-Calderón R; de Argila Fernández-Durán D
    Ann Allergy Asthma Immunol; 2008 Jun; 100(6):621-2. PubMed ID: 18592833
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapy of psoriasis vulgaris and psoriatic arthritis with etanercept].
    Mrowietz U; Barth J; Boehncke WH; Rosenbach T; Wozel G
    J Dtsch Dermatol Ges; 2005 Jun; 3(6):470-2. PubMed ID: 15892851
    [No Abstract]   [Full Text] [Related]  

  • 19. Survival rate of etanercept for psoriasis in real life: a multicentre observational study.
    Herrera-Acosta E; Suárez-Pérez JA; Aguilera J; Gómez-García F; Jiménez-Puya R; Guimerá F; Mendiola MV; Herrera-Ceballos E
    Eur J Dermatol; 2014; 24(5):619-20. PubMed ID: 25115194
    [No Abstract]   [Full Text] [Related]  

  • 20. [Psoriasis and psoriatic rheumatism: effectiveness of etanercept for cutaneous and joint lesions].
    Paul C; Solignac M
    Ann Dermatol Venereol; 2010 Apr; 137(4 Suppl):13-5. PubMed ID: 20510165
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.